These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23626669)

  • 1. Designed ankyrin repeat proteins: a new approach to mimic complex antigens for diagnostic purposes?
    Hausammann S; Vogel M; Kremer Hovinga JA; Lacroix-Desmazes S; Stadler BM; Horn MP
    PLoS One; 2013; 8(4):e60688. PubMed ID: 23626669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitor.
    Villard S; Lacroix-Desmazes S; Kieber-Emmons T; Piquer D; Grailly S; Benhida A; Kaveri SV; Saint-Remy JM; Granier C
    Blood; 2003 Aug; 102(3):949-52. PubMed ID: 12676786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study.
    Werwitzke S; Geisen U; Nowak-Göttl U; Eichler H; Stephan B; Scholz U; Holstein K; Klamroth R; Knöbl P; Huth-Kühne A; Bomke B; Tiede A
    J Thromb Haemost; 2016 May; 14(5):940-7. PubMed ID: 26988717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope mapping via selection of anti-FVIII antibody-specific phage-presented peptide ligands that mimic the antibody binding sites.
    Kahle J; Orlowski A; Stichel D; Becker-Peters K; Kabiri A; Healey JF; Brettschneider K; Naumann A; Scherger AK; Lollar P; Schwabe D; Königs C
    Thromb Haemost; 2015 Feb; 113(2):396-405. PubMed ID: 25520269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative measurement of anti-factor VIII antibody by Bethesda assay and ELISA reveals restricted isotype profile and epitope specificity.
    Towfighi F; Gharagozlou S; Sharifian RA; Kazemnejad A; Esmailzadeh K; Managhchi MR; Shokri F
    Acta Haematol; 2005; 114(2):84-90. PubMed ID: 16103630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the ortholog approach for hemophilia treatment complicated by factor VIII inhibitors.
    Zakas PM; Vanijcharoenkarn K; Markovitz RC; Meeks SL; Doering CB
    J Thromb Haemost; 2015 Jan; 13(1):72-81. PubMed ID: 25315236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenicity of putative phospholipid membrane-binding residues in factor VIII.
    Barrow RT; Healey JF; Jacquemin MG; Saint-Remy JM; Lollar P
    Blood; 2001 Jan; 97(1):169-74. PubMed ID: 11133757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A.
    Batty P; Moore GW; Platton S; Maloney JC; Palmer B; Bowles L; Pasi KJ; Rangarajan S; Hart DP
    Thromb Haemost; 2015 Oct; 114(4):804-11. PubMed ID: 26063073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ELISA system for detection of immune responses to FVIII: a study of 246 samples and correlation with the Bethesda assay.
    Sahud MA; Pratt KP; Zhukov O; Qu K; Thompson AR
    Haemophilia; 2007 May; 13(3):317-22. PubMed ID: 17498082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity profile of anti-factor VIII antibodies with designed synthetic peptides mimicking epitopes of the C2 and a1 domains.
    Chaves DG; Velloso-Rodrigues C; Moreau V; Nguyen C; Villard S; Belisário AR; Granier C; Santoro MM
    Br J Haematol; 2008 May; 141(5):708-15. PubMed ID: 18422780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The humoral response to human factor VIII in hemophilia A mice.
    Healey JF; Parker ET; Barrow RT; Langley TJ; Church WR; Lollar P
    J Thromb Haemost; 2007 Mar; 5(3):512-9. PubMed ID: 17181826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of inhibitors to FVIII with an ELISA in congenital and acquired haemophilia A.
    Lindgren A; Wadenvik H; Tengborn L
    Haemophilia; 2002 Sep; 8(5):644-8. PubMed ID: 12199673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A flow cytometry evaluation of anti-FVIII antibodies: correlation with ELISA and Bethesda assay.
    Irigoyen MB; Primiani L; Felippo M; Candela M; Bianco RP; De Bracco MM; Galassi N
    Haemophilia; 2011 Mar; 17(2):267-74. PubMed ID: 21070488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinuous epitopes on the C2 domain of coagulation Factor VIII mapped by computer-designed synthetic peptides.
    Lebreton A; Moreau V; Lapalud P; Cayzac C; André S; Nguyen C; Schved JF; Lavigne G; Granier C
    Br J Haematol; 2011 Nov; 155(4):487-97. PubMed ID: 21933172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low detection rate of antibodies to non-functional epitopes on factor VIII in patients with hemophilia A and negative for inhibitors by Bethesda assay.
    Ling M; Duncan EM; Rodgers SE; Street AM; Lloyd JV
    J Thromb Haemost; 2003 Dec; 1(12):2548-53. PubMed ID: 14675091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of human B domain-specific anti-factor VIII monoclonal antibodies generated in transgenic mice.
    Lavigne-Lissalde G; Lacroix-Desmazes S; Wootla B; Tarrade C; Schved JF; Kaveri SV; Granier C; Villard-Saussine S
    Thromb Haemost; 2007 Jul; 98(1):138-47. PubMed ID: 17598006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic biosensor to distinguish between inhibitory and non-inhibitory factor VIII antibodies.
    Kocot C; Schindler AR; Le Blanc A; Schmalenberg M; Miesbach W; Spannagl M; Luppa PB
    Anal Bioanal Chem; 2015 Jul; 407(19):5685-93. PubMed ID: 25957847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism and kinetics of factor VIII inactivation: study with an IgG4 monoclonal antibody derived from a hemophilia A patient with inhibitor.
    Jacquemin MG; Desqueper BG; Benhida A; Vander Elst L; Hoylaerts MF; Bakkus M; Thielemans K; Arnout J; Peerlinck K; Gilles JG; Vermylen J; Saint-Remy JM
    Blood; 1998 Jul; 92(2):496-506. PubMed ID: 9657749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope mapping of polyclonal clotting factor VIII-inhibitory antibodies using phage display.
    Mühle C; Schulz-Drost S; Khrenov AV; Saenko EL; Klinge J; Schneider H
    Thromb Haemost; 2004 Mar; 91(3):619-25. PubMed ID: 14983240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.